GENERALIZED LIPODYSTROPHY
Clinical trials for GENERALIZED LIPODYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new GENERALIZED LIPODYSTROPHY trials appear
Sign up with your email to follow new studies for GENERALIZED LIPODYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Rare Fat-Loss disorder drug under safety review
Disease control CompletedThis study looked at how the body reacts to metreleptin, a daily injection for generalized lipodystrophy, a rare condition where people lose body fat. Researchers checked for antibodies that might affect the drug's safety or effectiveness. The study involved 11 patients and was d…
Matched conditions: GENERALIZED LIPODYSTROPHY
Phase: PHASE4 • Sponsor: Aegerion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 17, 2026 09:10 UTC
-
New drug shows promise for rare fat disorder in small trial
Disease control CompletedThis study tested a new drug called REGN4461 in 16 people with generalized lipodystrophy, a rare condition where the body lacks fat tissue, leading to severe metabolic problems like high blood sugar and high triglycerides. The drug aims to mimic a natural hormone (leptin) to impr…
Matched conditions: GENERALIZED LIPODYSTROPHY
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 12, 2026 13:43 UTC